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.2012.06Abstract The worldwide burden of diarrhoeal disease results in 1.5 million deaths annually in chil-
dren under the age of ﬁve. Emergency physicians are often the primary medical provider to care for
these children, so a ﬁrm understanding of diarrhoeal aetiology, microbiology, risk stratiﬁcation,
and treatment options is crucial. By using a focused history and physical exam with appropriately
targeted serum investigations and imaging studies, children may be accurately assessed for degree of
dehydration. Ultrasound imaging in particular is emerging as a rapid and reliable tool for this pur-
pose. While oral rehydration remains essential ﬁrst-line treatment, more severe presentations war-
rant use of intravenous crystalloid for the correction of ﬂuid deﬁcit. A focus on proper patient
disposition and discharge instructions is also critical for prevention of further morbidity and to pre-
vent unnecessary emergency centre returns. This overview of recent literature provides the emer-
gency physician with a basic understanding of the evidence supporting management of paediatric
diarrhoea.
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DehydrationAbstract Le fardeau que repre´sente la maladie diarrhe´ique a` l’e´chelle mondiale entraıˆne chaque
anne´e 1,5 millions de de´ce`s chez les enfants de moins de 5 ans. Les urgentistes sont souvent les
premiers fournisseurs de soins me´dicaux pour ces enfants, ainsi une solide compre´hension de l’e´ti-
ologie, de la microbiologie, de la stratiﬁcation du risque et des possibilite´s de traitement de la
diarrhe´e est cruciale. En effectuant une anamne`se cible´e et un examen physique avec des recher-
ches de serum cible´es approprie´es et des e´tudes par imagerie, le degre´ de de´shydratation des
enfants peut eˆtre e´value´ avec pre´cision. L’imagerie par ultrasons en particulier apparaıˆt comme
un outil rapide et ﬁable a` cette ﬁn. Alors que la re´hydratation orale reste essentielle en tant
que premier traitement, des affections plus graves justiﬁent l’utilisation de cristalloı¨des par intra-
veineuse aﬁn de corriger le de´ﬁcit liquidien. Se concentrer sur des instructions de disposition et de
sortie du patient correctes est tout aussi fondamental pour la pre´vention d’une plus grande mor-
bidite´ et pour pre´venir un retour inutile en service d’urgence. Cette pre´sentation des ouvrages
re´cents fournit a` l’urgentiste une compre´hension de base des faits probants e´tayant la prise en
charge de la diarrhe´e pe´diatrique.
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 African countries hold 9 of the 10 highest national under-
ﬁve-year mortality rates.
 Eighty percent of diarrhoea-related mortalities occur within
Africa and southern Asia.
 Over the last decade, progress in the treatment of diarrhoea
has been slow in Africa.
What’s new?
 Aetiology of diarrhoea is largely dependent on geographic
and seasonal factors, with important treatment differences
in certain situations.
 Physical exam should focus on capillary reﬁll time, mucous
membranes, presence/absence of tears, and overall
appearance.
 Ultrasound is a new, inexpensive, rapid, and effective imag-
ing modality to assess dehydration.
 Management of dehydration depends on degree of ﬂuid loss,
and intravenous ﬂuids should generally only be used in
severe cases.
 Effective parental guidance at discharge is important to pre-
vent worsening of dehydration after an emergency centre
admission.Background
Despite a half-century of public health initiatives, treatment
advances, and improved diagnostic tools, acute diarrhoeal ill-
ness remains one of the two leading causes of death in paedi-
atric populations.1,2 According to the most recent estimates
from the World Health Organization (WHO), there are
approximately 2.5 billion cases of diarrhoeal illness each year.
The burden of disease is especially severe in the paediatric
population, resulting in 1.5 million deaths annually in children
under the age of ﬁve. Second only to pneumonia, diarrhoea isresponsible for 3% of neonatal mortality and 25% of post-na-
tal mortality. These numbers together account for more paedi-
atric deaths than AIDS, measles, and malaria combined.2
A disproportionate burden of this morbidity and mortality
falls on developing countries, with 80% of diarrhoea-related
mortalities occurring within Southern Asia and Africa.2 Even
among these continents, not all nations are equally affected.
Six countries alone (India, Nigeria, China, Pakistan, DR Con-
go, and Ethiopia) account for 50% of worldwide deaths under
5 years of age.3
Over the last 30 years the incidence of diarrhoea-related
mortality has dramatically decreased. Following introduction
of oral rehydration salts (ORS) and educational programs lar-
gely spearheaded by the WHO, diarrhoea-related annual mor-
tality dropped from 13.6 to 4.9 deaths per 1000 children under
ﬁve.4 Evidence has shown large-scale diarrhoea and dehydra-
tion treatment programs to be effective worldwide; Egypt
showed a 74% reduction in infant mortality from 1981 to
1990 and Brazil showed a 67% reduction in infant mortality
from 1980 to 1989 through improved awareness and use of
oral rehydration.5 But even with the success of these programs,
mortality rates remain unacceptably high. Also, over the last
5 years, global diarrhoea-related child mortality has appeared
to remain stable.6
Emergency physicians ﬁnd themselves on front lines of pub-
lic health. It is therefore essential for practitioners in these set-
tings to be able to determine the general aetiology of
diarrhoeal illness while identifying and treating ﬂuid or electro-
lyte disturbances. Also vital to emergency management is
patient disposition, with a focus on prevention and education.
In some settings, emergency physicians may be the sole medi-
cal provider for the patient; in these cases their role becomes
even more crucial.
Deﬁnitions
Diarrhoea may be divided into three categories: acute watery
diarrhoea, acute haemorrhagic/dysenteric diarrhoea, and per-
sistent/chronic diarrhoea. There is a lack of consensus on the
precise deﬁnition of each of these terms, and on the deﬁnition
of diarrhoea itself.7 While the WHO deﬁnes diarrhoea as the
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distinct episodes delineated by >2 consecutive days without
diarrhoea), the Infectious Disease Society of America (IDSA)
considers diarrhoea as ‘‘an alteration in a normal bowel
movement characterized by an increase in water content, vol-
ume, or frequency of stools,’’ and further characterizes infec-
tious diarrhoea as due to any infectious aetiology, ‘‘often
accompanied by symptoms of nausea, vomiting, or abdomi-
nal cramps’’.8 These symptoms overlap with the diagnosis
of acute gastroenteritis (AGE), an infectious illness character-
ized by acute diarrhoea, with or without nausea, vomiting, fe-
ver, and abdominal pain.9 A systematic review by Johnston
et al. performed in 2010 highlighted 64 unique deﬁnitions
and 46 unique primary outcomes used in randomized con-
trolled trials involving paediatric diarrhoea.10 This presents
a challenge to clinicians, requiring increased attentiveness
when applying evidence-based decision rules to practice. In
clinical settings, the terms AGE and acute diarrhoea are fre-
quently used interchangeably, but it is important to consider
non-infectious aetiologies including medication effects or sys-
temic conditions.11
Persistent diarrhoea – aetiology
This document will focus on acute disease, generally accepted
as an episode lasting <14 days duration.8 Nonetheless, emer-
gency physicians should be cognizant of conditions which
may lead to prolonged courses of disease. A recent study in
Turkey examined the cases of persistent (>14 days) diarrhoea
in children under the age of 2, and found the majority to be
suffering from milk protein allergy (54%). Less common diag-
noses included coeliac disease (17%) and lymphangiectasia
(12%).12 All patients presenting in areas where HIV is highly
endemic must be screened for the disease, as diarrhoea inci-
dence, severity, and mortality are signiﬁcantly higher in chil-
dren with HIV/AIDS.4
Acute diarrhoea – aetiology
The aetiology of acute diarrhoea is largely dependent on geo-
graphic and seasonal factors. The leading cause of severe
dehydrating diarrhoea worldwide is rotavirus, responsible
for an estimated 16–61% of all cases of AGE, 14–45% of
diarrhoeal-associated hospitalizations, 20% of diarrhoeal-
associated deaths and approximately 6% of all-cause deaths
<5 years of age.6,13–15 Primarily spread via faecal-oral trans-
mission, rotavirus manifests with watery diarrhoea, vomiting,
and low-grade fever, with a peak incidence in the rainy sea-
son.1,11 Other notable viral agents include norovirus, sapovi-
rus, adenovirus, and astrovirus, all of which are likely
transmitted faecal-orally and have minor epidemiologic dif-
ferences that are beyond the scope of this paper. One excep-
tion is norovirus, which often presents with worse vomiting
than diarrhoea compared to rotavirus and is associated with
AGE outbreaks and non-bacterial food-borne illness in devel-
oped countries.11
Important bacterial agents responsible for diarrhoea in-
clude Escherichia coli, Shigella species, Campylobacter jejuni,
Vibrio cholerae, Salmonella species, and less commonly
Clostridium difﬁcile.1,14,16 Of these, enterotoxigenic E. coli
(ETEC) is the major cause of paediatric ‘traveller’s diarrhoea,’followed by Shigella and Salmonella species.13 ETEC and
Salmonella are typically self-limited and often result in a
watery diarrhoea, while patients with Shigella are more likely
to present with haemorrhagic stools. Entero-haemorrhagic/
shiga-like toxin producing E. coli (EHEC), particularly
O157:H7, is associated with haemolytic-uremic syndrome
(HUS). While this pathogen is generally found in Europe
and parts of North and South America, outbreaks have oc-
curred in southern Africa necessitating awareness worldwide.1
Local variations in healthcare infrastructure and climate result
in variable pathogen prevalence, but some useful information
can be gleaned from a large recent prospective cohort study
from a United States paediatric emergency centre. Of 1626 pa-
tients enrolled, 47% had a pathogen identiﬁed. Bacterial cases
accounted for 7%, viral 33%, parasitic 1%, and C. difﬁcile
toxin a surprising 7%.17 Additional data are required to assess
the clinical relevance of this C. difﬁcile toxin prevalence but it
lays a groundwork of expectations for practitioners in more
developed nations.18
Protozoan infection is uncommon and should only be
suspected if a patient’s history directly implicates a parasite:
a known contaminated water source, persistent haemorrhagic
diarrhoea despite adequate Shigella treatment, or microscopic
conﬁrmation. Pathogens of note include Entamoebahistolytica,
Isospora belli, Giardia, and Cryptosporidium. The latter two
are the most common parasitic causes of diarrhoea in devel-
oped countries while Entamoeba histolytica is more common
in developing nations.14 Cryptosporidium is generally self-lim-
ited but of concern in immunocompromised or undernour-
ished patients.1,8 Isospora belli, while rare in developed areas,
should be considered in severely immunocompromised pa-
tients in tropical settings.19
Practitioners should also consider non-infectious causes
including inﬂammatory bowel disease, cystic ﬁbrosis, appendi-
citis, or intussusception.12,16,20
History
A thorough history can aid in both diagnosis and disposition
planning. Important aspects to discuss with guardians include
(1) onset and duration of symptoms; (2) stool characteristics
(bloody, watery, presence of mucous); (3) frequency and vol-
ume of stool; (4) oral intake of solid food and ﬂuid throughout
the period of illness, including breast milk; (5) presence or ab-
sence of associated symptoms including nausea, vomiting,
abdominal pain, or headaches; (6) presence or absence of infec-
tious signs or symptoms including fever, cough, or known re-
cent infections; (7) symptoms of dehydration such as weight
loss, decreased urination, decreased tear production, tachycar-
dia, dry mouth, cool extremities, or orthostasis; and (8) any
epidemiologic risk factors, such as recent travel, crowded liv-
ing conditions or day-care use, raw/undercooked food con-
sumption, animal contacts, sick contacts, recent medication
use, underlying conditions such as HIV, and immunization
history.1,8,9
In addition to aiding in identiﬁcation of the diarrhoeal
pathogen, historical elements can aid in risk-stratifying paedi-
atric patients. A 2003 study by Porter et al. found a high sen-
sitivity (73–100%) for parentally reported data to predict
>5% dehydration, with a report of normal ﬂuid intake, nor-
mal urine output, and normal tearing all independently reduc-
ing the likelihood of signiﬁcant dehydration.21
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The primary goal of the physical exam is to assess the severity
of ﬂuid deﬁcit. Secondary to this is identiﬁcation of complicat-
ing conditions such as malnutrition, altered mental status, or
co-existing infection. The WHO dehydration classiﬁcation sys-
tem (1995) uses a four-item assessment (general appearance,
sunken eyes, degree of thirst, and skin turgor), and divides
dehydration into three levels, none, some, and severe, graded
to guide treatment. Mild/no dehydration is deﬁned as a loss
of baseline body weight of <5%, while moderate dehydration
falls between 5–10% and severe >10%.1 When a patient’s
baseline weight is unavailable, as it often will be, estimates
should be made using ideal weight-for-age, physical exam ﬁnd-
ings and historical data.
Steiner et al. performed a systematic review of the accuracy
and precision of physical exam and laboratory ﬁndings to eval-
uate dehydration in children.20 Included in this review were
only studies comparing weight at presentation to re-hydration
weight as a gold standard for ﬂuid deﬁcit. The summary data
demonstrated that physical exam ﬁndings were often imprecise
and varied in their predictive value between examiners. Over-
all, the three most predictive signs were prolonged capillary re-
ﬁll time (likelihood ratio (LR), 4.1; 95% CI, 1.7–9.8),
abnormal skin turgor (LR, 2.5; 95% CI, 1.5–4.2), and abnor-
mal respiratory pattern (LR, 2.0; 95% CI, 1.5–2.7).
Rarely should a clinician use a single exam ﬁnding to deter-
mine treatment or disposition. Gorelick et al. prospectively
evaluated a 10-point scale for predicting paediatric dehydra-
tion, deﬁned as a deﬁcit of >5% body weight from baseline.23
Exclusion criteria included malnutrition, prolonged illness,
and electrolyte disturbances, limiting the applicability of ﬁnd-
ings. The signs tested were: decreased skin elasticity, capillary
reﬁll time >2 seconds, general appearance, absence of tears,
abnormal respirations, dry mucous membranes, sunken eyes,
abnormal radial pulse, tachycardia >150 bpm, and decreased
urine output. While individual factors were non-diagnostic, the
presence of 3 or more of these signs had a sensitivity of 87%
and speciﬁcity of 82% (LR, 4.9; 95% CI, 3.3–7.2). Four
selected signs (capillary reﬁll time, dry mucous membranes,
absence of tears, and abnormal overall appearance) were tested
as subset. The presence of 2 or more of these was also predic-
tive (LR, 6.1; 95% CI, 3.8–9.8).
In the setting of malnutrition, many exam ﬁndings for
dehydration are confounded. Among these are skin elasticity,
sunken eyes, and overall appearance. In these situations, focus
should be placed on signs speciﬁc to hypovolemia: urine out-
put, tear production, and subjective thirst.1 Even more chal-
lenging is the overlap between shock and dehydration, which
both manifest similarly. If a patient appears severely dehy-
drated but has no history of diarrhoea or meets sepsis criteria,
treatment for septic shock should commence.
Role of imaging studies
Imaging has played a very small role in the diagnostic workup
of diarrhoeal illness. Abdominal plain ﬁlms are nonspeciﬁc
and often show dilated loops of bowel in patients with diar-
rhoea, while abdominal CT scans rarely lead to changes in
therapeutic approach.16 A notable exception is the patient with
an acute abdomen in whom CT imaging may clarify the needfor surgical intervention. Examples include intestinal perfora-
tion as a complication of Salmonella typhi infection and acute
appendicitis, which presents with associated diarrhoea in up to
41% of children less than 3 years old.20,24
Each year the body of literature on ultrasound (US) imag-
ing becomes more robust, while access to bedside ultrasonog-
raphy becomes available to a larger population. In addition
to diagnosing intra-abdominal pathology that may be associ-
ated with diarrhoea such as appendicitis and intussusception,
US has been used in the assessment of dehydration. Levine
et al. examined a cohort of children in three rural Rwandan
hospitals and found IVC/aorta ratio of 0.82 to be 93% sensi-
tive and 59% speciﬁc, with LR+ of 2.3 (95% CI, 1.5–3.5)
for detecting dehydration, deﬁned as P10% body weight loss
at presentation.25 IVC compressibility was not a reliable mea-
sure of dehydration in this study. A similar trial by Chen et al.
performed in an urban US emergency centre found IVC/aorta
ratio of 0.8 to be 86% sensitive and 56% speciﬁc for detecting
dehydration P5%.26
Role of laboratory testing
Multiple studies have examined laboratory tests for the assess-
ment of dehydration in children, including blood urea nitrogen
(BUN), BUN/creatinine ratio, serum electrolytes, and the
presence of acidosis (using bicarbonate levels or base deﬁcit
measurement).9,22 Of these, BUN and serum bicarbonate have
both been associated with clinically signiﬁcant dehydration,
although evidence is mixed. Depending on cut-off values, ele-
vated BUN levels demonstrate a sensitivity between 38–44%
and speciﬁcity of 55–99% for P5% dehydration.22 Vega and
Avner found that serum bicarbonate <17 mEq/L was 94%
sensitive for >10% dehydration (95% CI, 71–100%).27 Nagler
et al. showed that end-tidal carbon dioxide levels correlate well
with serum bicarbonate values in children with AGE, poten-
tially allowing for an accurate, non-invasive proxy measure
of dehydration.28
Electrolyte measurement is appropriate in patients with
altered mental status, moderate/severe dehydration, clinical
signs of electrolyte disorders (weakness, cramping, seizures),
or in children <6 months.9 While resource limitations may
not allow for laboratory testing in all situations, Wathen
et al. showed that serum electrolyte measurement changed the
management in a full 10.4% of 182 patients receiving IV ﬂuid
for dehydration in a US paediatric emergency centre, and
should at least be considered in all moderate to severe cases.29
Blood glucose testing of hypoglycaemia should be performed
whenever available, as diarrhoea places a child at increased risk
and is often clinically undetectable. A study in the US of chil-
dren with AGE and normal mental status found 9.2% to be
hypoglycaemic with a range from 34 to 59 mg/dL.30
Stool cultures are rarely indicated in acute diarrhoea. The
majority of diarrhoea in developed countries is viral and there-
fore culture yield is extremely low. While developing countries
have higher incidence of bacterial-associated diarrhoea, results
rarely impact management.
Acute medical management
The cornerstone of paediatric diarrhoea management is to
ensure proper hydration, whether through oral rehydration
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introduction of feeding when appropriate.2,6 The decision be-
tween ORT and IVT depends on the degree of dehydration
and the clinical presentation. The WHO recommends that
all patients with severe diarrhoea (>10% dehydration) to
be treated with rapid IVT while those with mild/moderate
diarrhoea be given a trial of ORT.1 However, all children
who are able to drink should be given immediate oral rehy-
dration solution (ORS) regardless of the overall treatment
plan. Contraindications to ORT include altered mental sta-
tus, inability to protect the airway, and suspected ileus; vom-
iting is not a contraindication.1,9,14 A Cochrane review
comparing the two treatment modalities in children with
AGE showed no signiﬁcant differences in weight gain, so-
dium imbalance, duration of diarrhoea, or total ﬂuid intake
at 6 and 24 h between the two groups.31 Only one in 25 chil-
dren (95% CI, 14–100) treated with ORT required IVT due
to inadequate rehydration.
Reduced osmolarity ORS (245 mOsm/L) has resulted in
fewer unanticipated IV ﬂuid infusions, lower stool volume,
and less vomiting in hospitalized patients with acute diarrhoea,
when compared to the WHO standard formulation
(310 mOsm/L).32,33 Additionally, polymer-based ORS may
have some additional advantages although further study is still
needed.34 For patients with some dehydration, ORS should be
initiated at a rate of 75 ml/kg over the ﬁrst 4 h.1,14,35 This rate
should be a rough guide for practitioners, with frequent re-
assessments and alterations in treatment strategy based on
clinical indicators; for example very frequent watery stools
may require an increase in total ORS volume. Children who re-
main thirsty with no signs of over-hydration should be allowed
to continue taking ORS. Nasogastric (NG) tube hydration
should be considered in children who are not tolerating oral
ﬂuids, and as a bridge therapy in children for whom intrave-
nous or intraosseous (IO) access is unavailable. NG hydration
is equally as effective as IVT in moderately dehydrated chil-
dren.36 Beneﬁts of ORT include natural barriers against
over-hydration (thirst decreases with ﬂuid deﬁcit), non-inva-
sive and rapid initiation of treatment, cost-savings over IVT,
and less stress for child and guardian.
For the severely dehydrated, obtunded, or hemodynami-
cally unstable patient, IVT should be ﬁrst-line therapy. In
patients with challenging IV access, IO or NG hydration
should be started immediately, and all children who can
safely drink should take additional ORS. The WHO recom-
mends that infants (< 12 months) receive 30 ml/kg IVT over
1 h followed by 70 ml/kg over 5 h. Older children should re-
ceive 30 ml/kg over 30 minutes and 70 ml/kg over the next
2.5 h, with frequent re-assessment.1 King et al. recommend
an initial rate of 20 ml/kg until mental status and vital signs
improve, followed by an infusion of twice standard mainte-
nance rates.35 Normal saline or lactated ringers may be given
as an initial bolus, followed by 5% dextrose ½ normal saline
for maintenance therapy.14,35 To replace on-going losses,
20 mEq/L of potassium chloride may be added to maintain
ﬂuids.
Both hypo- and hypernatremia may complicate the course
of diarrhoeal illness and should prompt hospitalization.
Hyponatraemia may be safely and slowly corrected with
ORS in most cases, but an important exception is the malnour-
ished/oedematous child for whom ORS provides excessive so-
dium and requires dilution.1 Hypernatremia is often secondaryto inadequate ﬂuid repletion or repletion with hypertonic ﬂu-
ids. In these children, slow correction of the electrolyte distur-
bance is crucial, as rapid over-correction may lead to cerebral
oedema, seizures, or death. IV ﬂuid repletion places the child
at higher risk of over-correction compared to ORT and must
be monitored closely, with any changes in mental status
prompting immediate re-assessment.
Low-dose zinc supplementation (10–20 mg/day for 10–
14 days) is a standard recommendation by the WHO, although
in recent years the speciﬁc role of zinc has been called into
question.1,7,37 Despite strong evidence from multiple studies
that zinc decreases severity and duration of illness, two system-
atic reviews by Patel et al. highlight heterogeneity of responses
to zinc in both acute treatment and preventative therapy.5,37,38
Also, many studies of diarrhoeal illness are conducted in devel-
oping nations where zinc deﬁciency is more common, obscur-
ing the role of zinc in developed settings.6 However, while the
questions regarding the appropriate target population are
being answered through further study, zinc should remain a
component of acute diarrhoeal treatment. A systematic review
by Walker and Black showed a 23% reduction in mortality
and decreased risk of hospitalization in zinc-treated patients
with diarrhoea.33,39
Recommendations for antibiotics in acute diarrhoea vary
widely, largely due to different practice environments and
overall goals of care. The WHO, working chieﬂy to reduce
paediatric mortality in developing countries, recommends
avoiding routine administration of antibiotics in almost all
cases of acute diarrhoea except for notable disease states:
severe or epidemic V. cholerae infections (treatment should
be guided by local antibiogram patterns), laboratory-proven
Giardia (treated with metronidazole), or cases of haemor-
rhagic diarrhoea considered possible Shigella infections (trea-
ted with a ﬂuoroquinolone).1,8 Holtz et al. discourage the
administration of antibiotics to patients with acute haemor-
rhagic diarrhoea until a clear treatment-responsive pathogen
is identiﬁed, and recommend hospital admission to allow
time for stool cultures to grow and to prevent community
spread of bacterial illness.16 This recommendation is speciﬁc
for regions with low incidence of shigellosis, as Shigella is
life-threatening and suspected cases should be treated. The
Infectious Disease Society of America further cautions
against over-treatment, given worldwide increase in quino-
lone-resistant Campylobacter infections and multi-drug resis-
tant Salmonella strains. Antibiotics should be avoided in
suspected cases of EHEC, as antimicrobial therapy has not
been shown to improve symptoms of O157 infections but
is associated with increased risk of HUS.8 Antibiotic-induced
diarrhoea is common, especially in countries where antibiot-
ics are widely available without prescription. In these cases,
discontinuation of the antimicrobial agent may be sufﬁcient
for treatment. In severe cases, testing for C. difﬁcile toxin
should be considered.40
Adjunct medical interventions have been examined, partic-
ularly in developed countries. These ‘‘anti-diarrhoeal’’ drugs
are contraindicated by the WHO for use in any situation, as
no practical improvement in outcomes has yet been associated
with these agents. The following medications, if used at all,
should only be prescribed with caution by experienced practi-
tioners: Racecadotril (acetorphan), which reduces intestinal
secretions, has been shown to decrease stool duration, output,
and number in a meta-analysis of children with AGE.6,11,41
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decrease diarrhoeal duration in a meta-analysis with a pooled
weighted mean difference of 22.7 h.6,42 Bismuth subsalicylate
has been shown to safely decrease the duration and symptoms
of watery diarrhoea, particularly when due to rotavirus.11,43,44
Probiotics have been shown to be highly effective in limiting
viral diarrhoea duration, but efﬁcacy is limited to two strains:
Lactobacillus rhamnosus GG and Saccharomyces boulardii.45
Other adsorbents and antimotility agents, including lopera-
mide, codeine, diphenoxylate, kaolin, and activated charcoal
have limited data or safety concerns and should not be
used.11,43,44Disposition planning
Admission to the hospital should be considered for children
with severe dehydration or moderate dehydration and inability
to take oral ﬂuids, those with serious co-morbidities, haemor-
rhagic diarrhoea, electrolyte disturbances, or for any child with
a poor social situation and low likelihood of proper home
therapy. If a child is taking proper oral hydration, appears
to be improving in the emergency centre, and has no underly-
ing medical conditions, discharge to home is likely a safe
choice. Borderline cases should be referred to paediatric obser-
vation units (OU). AGE and dehydration have been speciﬁ-
cally examined in these units, with one study of 430 OU
admissions resulting in an 81% discharge rate within 24 h.46
C. difﬁcile cases should be isolated, but any admitted diarrhoea
case should prompt strict practices to prevent nosocomial
infection.
Clear and comprehensive discharge instructions are
instrumental to ensure optimal treatment, prevent prolonged
courses of diarrhoea, and reduce the number of children who
fail outpatient management. A survey of parents in the US
showed that only 53% were treated for diarrhoea with rec-
ommended ﬂuids, while some parents giving ﬂuids high in
simple sugars and some giving inappropriate medical treat-
ments.47 Guardians should be taught to give more ﬂuid than
usual. Mothers should be strongly encouraged to continue
breastfeeding, as it has been proven protective against
diarrhoeal illness.1 Other appropriate ﬂuids include ORS
solution, salty (3 g/l) drinks, soup, or broth, plain clean
water, or unsweetened juice.1 Sweetened drinks should be
avoided due to the potential for osmotic diarrhoea and
hypernatremia.
Early re-feeding has been shown to be appropriate and ben-
eﬁcial for children with acute diarrhoea, with no increased risk
of vomiting, IV ﬂuid requirements, or persistent diarrhoea.48
Food should be nutritive, and frequent small feeds are better
than large meals. The ‘‘BRAT’’ diet (bananas, rice, applesauce,
toast) is not associated with any convincing evidence and is
low in energy density, protein, and fat. It should not be recom-
mended to parents.13
Basic hygiene techniques such as proper water ﬁltration and
sourcing should be discussed as is appropriate, given that 88%
of deaths due to diarrhoea may be attributable to unsanitary
drinking water, inadequate sanitation, and poor hygiene.3
Medical staff and parents should be strongly encouraged to
wash hands often with soap and water to prevent disease trans-
mission, and children of appropriate age should be taught the
same.Finally, the WHO has recommended that rotavirus
vaccination should be implemented as a part of all national
immunization programs to reduce diarrhoeal mortality.33
These vaccines reduce diarrhoeal incidence, hospitalization
due to diarrhoea, and overall child mortality.49 Although spe-
ciﬁc formulations are beyond the scope of this paper, newly
developed rotavirus vaccines have been shown to be safe and
effective, and should be discussed with the child’s guardian
as part of prevention planning.50
Conclusions
As the WHO stated in their 2009 report on child mortality,
‘‘although progress is being made, much more remains to be
done.’’ Physicians operating in emergency settings will be fre-
quently faced with the task of treating children with acute diar-
rhoea and should be prepared to make evidence-based
diagnostic and treatment decisions. Using a combination of his-
torical clues, physical exam ﬁndings, ultrasound imaging (when
available), and laboratory testing, the degree of dehydration can
be accurately and rapidly identiﬁed. Once risk-stratiﬁed,
patients should be treated accordingly, with an emphasis on
correcting ﬂuid deﬁcit and supplying nutrients/electrolytes.
The role of quality discharge planning cannot be understated,
as appropriate anticipatory guidance has the potential to
decrease the frequency and severity of future episodes.
Appendix A. Short answer questions
1. Which of the following infectious agents is responsible for
the greatest majority of morbidity and mortality secondary
to diarrhoea worldwide?
a. Norovirus
b. Escherichia coli O157:H7
c. Rotavirus
d. Campylobacter jejuni
e. Vibrio cholerae
2. A 20 kg child presents to your emergency centre with 3 days
of watery diarrhoea but no vomiting. History is positive for
decreased tearing and an estimated 3 kg weight loss. Exam
is notable for decreased capillary reﬁll and dry mucous
membranes. What ﬂuid repletion strategy is most
appropriate?
a. Management at home, recommend 200 ml intake per
watery stool
b. Oral hydration in the centre, starting with 1.5 l over 4 h
c. Rapid IVF only, bolus of 400–600 ml followed by twice
maintenance rate
d. Trial of oral hydration while preparing for IVF as
above, consider observation unit admission
e. Immediate admission and inpatient ward management
3. Given the supporting evidence presented in this article,
which of the following is not currently recommended for
the treatment of acute diarrhoea?
a. Activated charcoal
b. Bismuth subsalicylate
c. Diosmectite
d. Probiotics
e. Racecadotril
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